5099 related articles for article (PubMed ID: 6321859)
1. Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture.
Vyth-Dreese FA; de Vries JE
Leuk Res; 1984; 8(1):1-14. PubMed ID: 6321859
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--II. Inhibition of lymphoproliferative responses.
Vyth-Dreese FA; de Vries JE
Leuk Res; 1984; 8(1):15-26. PubMed ID: 6321861
[TBL] [Abstract][Full Text] [Related]
3. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
Yodoi J; Teshigawara K; Nikaido T; Fukui K; Noma T; Honjo T; Takigawa M; Sasaki M; Minato N; Tsudo M
J Immunol; 1985 Mar; 134(3):1623-30. PubMed ID: 2578514
[TBL] [Abstract][Full Text] [Related]
4. Tac-positive, HTLV-negative, T helper phenotype chronic lymphocytic leukemia cells.
Pandolfi F; De Rossi G; Ranucci A; Bonomo G; Pasqualetti D; Napolitano M; Manzari V
Blood; 1985 Jun; 65(6):1531-7. PubMed ID: 2986747
[TBL] [Abstract][Full Text] [Related]
5. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
Platsoucas CD; Good RA
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
9. T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation.
Kurnick JT; Warrens AR; Moscicki RA; Leary CP
Clin Immunol Immunopathol; 1983 Jun; 27(3):444-51. PubMed ID: 6223760
[TBL] [Abstract][Full Text] [Related]
10. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
11. In vitro function of a T-cell chronic lymphocytic leukemia with suppressor cell phenotype.
Crosier PS
Aust N Z J Med; 1986 Jun; 16(3):389-92. PubMed ID: 2946284
[TBL] [Abstract][Full Text] [Related]
12. Malignant clonal expansion of large granular lymphocytes with a Leu-11+, Leu-7- surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2.
Koizumi S; Seki H; Tachinami T; Taniguchi M; Matsuda A; Taga K; Nakarai T; Kato E; Taniguchi N; Nakamura H
Blood; 1986 Nov; 68(5):1065-73. PubMed ID: 2945603
[TBL] [Abstract][Full Text] [Related]
13. Leu 11+ T gamma cell chronic lymphocytic leukemia with partially activated natural killer function and its further activation by recombinant IL2 in vitro.
Tagawa S; Tokumine Y; Ueda E; Waki K; Kanayama Y; Taniguchi N; Nakanishi T; Inoue R; Kitani T
Blood; 1986 Oct; 68(4):846-52. PubMed ID: 2944554
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of human T-cell leukemia/lymphoma virus in neoplastic T cells induced to proliferate by phorbol ester and interleukin-2.
Vyth-Dreese FA; de Vries JE
Int J Cancer; 1983 Jul; 32(1):53-9. PubMed ID: 6602780
[TBL] [Abstract][Full Text] [Related]
15. In vitro generation of NK-like activity in human PBL co-cultured with fresh T leukaemia cells.
Matera L; Foa R; Moore M
J Clin Lab Immunol; 1984 Oct; 15(2):85-90. PubMed ID: 6335181
[TBL] [Abstract][Full Text] [Related]
16. Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells.
Itoh K; Platsoucas CD; Tilden AB; Pollock RE; Balch CM
Cell Immunol; 1987 Sep; 108(2):283-96. PubMed ID: 3113741
[TBL] [Abstract][Full Text] [Related]
17. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
18. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody studies in B-cell chronic lymphocytic leukemia and allied disorders.
Aisenberg AC; Wilkes BM
Hematol Oncol; 1983; 1(1):13-9. PubMed ID: 6610619
[TBL] [Abstract][Full Text] [Related]
20. Helper cell function of Leukemic Leu-2a+, histamine receptor+, T gamma lymphocytes.
Siegal FP; Rambotti P; Siegal M; Lopez C; Smith M; Davies TF; Osband M; Estren S
J Immunol; 1982 Oct; 129(4):1775-81. PubMed ID: 6213720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
